BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28370441)

  • 1. Adverse skin reaction to Secukinumab.
    Peigottu MF; Montesu MA
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):e432-e433. PubMed ID: 28370441
    [No Abstract]   [Full Text] [Related]  

  • 2. Secukinumab-Induced Psoriasiform Eruption.
    Sladden MJ; Sladden CS; Gulliver WPF
    JAMA Dermatol; 2017 Nov; 153(11):1194-1195. PubMed ID: 28768308
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent angular cheilitis after secukinumab injections.
    Hitaka T; Sawada Y; Okada E; Nakamura M
    Australas J Dermatol; 2018 Feb; 59(1):e79-e80. PubMed ID: 28620989
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of bullous pemphigoid during treatment of psoriasis with adalimumab.
    Stausbøl-Grøn B; Deleuran M; Sommer Hansen E; Kragballe K
    Clin Exp Dermatol; 2009 Oct; 34(7):e285-6. PubMed ID: 19438555
    [No Abstract]   [Full Text] [Related]  

  • 5. Dermatitis during efalizumab treatment in a patient with psoriasis vulgaris.
    de Groot M; de Rie MA; Bos JD
    Br J Dermatol; 2005 Oct; 153(4):843-4. PubMed ID: 16181475
    [No Abstract]   [Full Text] [Related]  

  • 6. Brodalumab-induced palmar pustular eruption and joint swelling accompanied by muscle pains in two cases of psoriasis.
    Takahashi H; Sato K; Takagi A; Iizuka H
    J Dermatol; 2018 Nov; 45(11):e325-e326. PubMed ID: 29767849
    [No Abstract]   [Full Text] [Related]  

  • 7. Pityriasis rosea-like arranged eruption after infliximab therapy in a patient with psoriasis vulgaris.
    Ohtsuka T
    J Dermatol; 2014 Apr; 41(4):354-5. PubMed ID: 24617533
    [No Abstract]   [Full Text] [Related]  

  • 8. Eczematous eruption in patients with psoriasis during risankizumab treatment.
    Kromer C; Schön MP; Mössner R
    Eur J Dermatol; 2020 Oct; 30(5):599-601. PubMed ID: 33185530
    [No Abstract]   [Full Text] [Related]  

  • 9. Efalizumab-associated papular psoriasis: an adverse reaction to efalizumab in three cases.
    Antonucci A; Bardazzi F; Balestri R; Patrizi A
    J Dermatolog Treat; 2009; 20(1):61-2. PubMed ID: 18618361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphomatoid drug reaction to ustekinumab.
    Jung J; Levin EC; Jarrett R; Lu D; Mann C
    Arch Dermatol; 2011 Aug; 147(8):992-3. PubMed ID: 21844471
    [No Abstract]   [Full Text] [Related]  

  • 11. Urticarial vasculitis due do infliximab.
    Goulão J; Cunha H; Anes I; Bártolo E; Furtado C; Serrano P; Brandão FM
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):882-3. PubMed ID: 18462298
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to a letter from Dr Drago.
    Ohtsuka T
    J Dermatol; 2014 Sep; 41(9):865-566. PubMed ID: 25182299
    [No Abstract]   [Full Text] [Related]  

  • 13. Pityriasis rosea and pityriasis rosea-like eruption: can they be distinguished?
    Drago F; Ciccarese G; Rebora A; Parodi A
    J Dermatol; 2014 Sep; 41(9):864-5. PubMed ID: 25182298
    [No Abstract]   [Full Text] [Related]  

  • 14. Eyelid Dermatitis as a Side Effect of Interleukin-17A Inhibitors in Psoriasis.
    Teraki Y; Takahashi A; Inoue Y; Takamura S
    Acta Derm Venereol; 2018 Apr; 98(4):456-457. PubMed ID: 29327064
    [No Abstract]   [Full Text] [Related]  

  • 15. Eczematous drug eruption after ustekinumab treatment.
    Pernet C; Guillot B; Bessis D
    Arch Dermatol; 2012 Aug; 148(8):959-60. PubMed ID: 22911203
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of de novo psoriasis during nivolumab therapy for metastatic renal cell carcinoma: immunohistochemical analyses and clinical outcome.
    Ruiz-Bañobre J; Abdulkader I; Anido U; León L; López-López R; García-González J
    APMIS; 2017 Mar; 125(3):259-263. PubMed ID: 28233446
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis.
    Dang LJ; Lubel JS; Gunatheesan S; Hosking P; Su J
    Australas J Dermatol; 2014 Feb; 55(1):75-9. PubMed ID: 23651182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug eruption caused by secukinumab.
    Shibata M; Sawada Y; Yamaguchi T; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Okada E; Nakamura M
    Eur J Dermatol; 2017 Feb; 27(1):67-68. PubMed ID: 27748259
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse reactions during biological drug therapy in psoriasis:clinical series and a review of the literature.
    Montesu MA; Addis GM; Satta R; Cottoni F
    G Ital Dermatol Venereol; 2011 Aug; 146(4):273-81. PubMed ID: 21785393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flare of pustular psoriasis after initiating ustekinumab therapy.
    Wenk KS; Claros JM; Ehrlich A
    J Dermatolog Treat; 2012 Jun; 23(3):212-4. PubMed ID: 21254881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.